<DOC>
	<DOCNO>NCT02892019</DOCNO>
	<brief_summary>This study design explore lung function effect two dos indacaterol acetate , 75 μg 150 μg , pediatric asthma patient 6-11 year old , compare systemic exposure indacaterol plasma historical data adult , identify appropriate dose Phase III evaluation .</brief_summary>
	<brief_title>Efficacy Safety Indacaterol Acetate Delivered Via Concept1 Inhalation Device Children Greater Equal 6 Less Than 12 Years Age With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Male female child ≥ 6 year &lt; 12 year confirm diagnosis asthma least 1 year prior study enrollment . Written inform consent parent ( ) /legal guardian ( ) depend upon age local requirement consent assent patient . Patients receive daily treatment stable low dose Inhaled Corticosteroid ( ICS ) ( without additional controller ) , patient receive daily treatment stable middose ICS ( monotherapy together LTRA ) least 4 week prior Screening , able tolerate fluticasone propionate 100 μg b.i.d . inhaler start Visit 1 ( soon ) . Patients prebronchodilator FEV1 ≥ 50 % ≤ 90 % predict normal value patient start end Runin ( Visits 101 199 ) . Patients demonstrate increase FEV1 12 % within 30 minute administration 400 μg salbutamol/360 μg albuterol ( equivalent dose ) Visit 101 . All patient must perform reversibility test Visit 101 . Patients take middose ICS ( per GINA guideline ) combination LABA patient take highdose ICS . Evidence unstable disease within 4 week prior Screening ( Visit 1 ) . Patients asthma attack/exacerbation require systemic steroid ( SCS ) hospitalization emergency room visit within 3 month prior Visit 1 ( Screening ) 3 separate exacerbation 12 month precede Visit 1 . Suspected documented bacterial viral infection upper low respiratory tract , sinus middle ear resolve within 4 week Screening ( Visit 1 ) . Prior intubation asthma .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>indacaterol acetate , asthma , GINA 2015 , pediatrics</keyword>
</DOC>